Abstract
The optical radiation safety of various seasonal affective disorder (SAD) treatment lamps, sunrise simulators and daylight bulbs available on the UK market have been assessed using recognised guidelines. An analysis is included of the photometry of circadian entrainment by bright light therapy, with a justification for a melanopsin-based action spectrum for treatment efficacy. Parameters relating to both efficacy and phototoxicity risk, which are potentially relevant to bright light therapy treatment regimes, are considered. Unpredictable variations are highlighted which lead to the conclusion that several relevant photometric variables of treatment lamps need to be characterised to predict efficacy and potential hazards.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
